US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aardvark Therapeutics

7.95

+0.33004.33%

Post-market: 7.950.00000.00%18:33 EDT

Volume:30.08K

Turnover:237.59K

Market Cap:170.01M

PE:-12.27

High:7.99

Open:7.75

Low:7.75

Close:7.62

Loading ...

Overview Company News Filings

Aardvark Therapeutics Price Target Maintained With a $50.00/Share by Cantor Fitzgerald

Aardvark Therapeutics FY24 EPS (5.15) Down From ($1.82) YoY

Press Release: Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights

BUZZ-Ultragenyx Pharma up after JPMorgan PT raise

Aardvark Therapeutics Is Maintained at Buy by B of A Securities

Aardvark Therapeutics price target raised to $26 from $22 at BofA

Aardvark Therapeutics Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $22

THOMSON REUTERS

BofA Initiates Aardvark Therapeutics at Buy With $22 Price Target

MT Newswires Live

Aardvark Therapeutics Initiated at Buy by B of A Securities

Morgan Stanley Initiates Aardvark Therapeutics at Overweight

MT Newswires Live

Cantor Fitzgerald Initiates Aardvark Therapeutics at Overweight With $50 Price Target

MT Newswires Live

RBC Initiates Aardvark Therapeutics at Outperform With $21 Price Target, Speculative Risk Qualifier

MT Newswires Live

Aardvark Therapeutics initiated with an Outperform at RBC Capital

Kenneth Griffin Reports 5.6% Passive Stake in Aardvark Therapeutics as of Feb 14 - SEC Filing

THOMSON REUTERS

Sector Update: Health Care Stocks Mixed Thursday Afternoon

MT Newswires Live

Aardvark Therapeutics Shares Below IPO Price on Nasdaq Debut

MT Newswires Live

Aardvark Therapeutics Prices $94.2 Million IPO

MT Newswires Live

BRIEF-Aardvark Therapeutics Prices IPO Of 5.9 Million Shares At $16.00 Per Share

Aardvark Therapeutics Announces Pricing of Initial Public Offering

THOMSON REUTERS

Aardvark Therapeutics Inc - Prices IPO of 5,888,000 Shares at $16.00 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AARD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AARD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":7.95,"timestamp":1744747200000,"preClose":7.62,"halted":0,"volume":30084,"hourTrading":{"tag":"盘后","latestPrice":7.95,"preClose":7.95,"latestTime":"18:33 EDT","volume":32,"amount":252.85,"timestamp":1744756435073},"delay":0,"floatShares":5900000,"shares":21384400,"eps":-0.648,"marketStatus":"Closed","change":0.33,"latestTime":"04-15 16:00:00 EDT","open":7.75,"high":7.99,"low":7.75,"amount":237590.27025,"amplitude":0.031496,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.648,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1744790400000},"marketStatusCode":5,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":7.62,"preHourTrading":{"tag":"盘前","latestPrice":6.66,"preClose":7.62,"latestTime":"04:07 EDT","volume":1,"amount":6.66,"timestamp":1744704473569},"postHourTrading":{"tag":"盘后","latestPrice":7.95,"preClose":7.95,"latestTime":"18:33 EDT","volume":32,"amount":252.85,"timestamp":1744756435073},"volumeRatio":0.183992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AARD\",,,,,undefined,":{"symbol":"AARD","floatShares":5900000,"roa":"-32.35%","roe":"-50.70%","lyrEps":-0.74,"volumeRatio":0.183992,"shares":21384400,"dividePrice":0,"high":7.99,"amplitude":0.031496,"preClose":7.62,"low":7.75,"week52Low":4.88,"pbRate":"-3.11","week52High":19.58,"institutionHeld":0,"latestPrice":7.95,"eps":-0.648,"divideRate":0,"volume":30084,"delay":0,"ttmEps":-0.648,"open":7.75,"prevYearClose":16,"prevWeekClose":7.14,"prevMonthClose":7.51,"prevQuarterClose":7.51,"fiveDayClose":7.29,"twentyDayClose":9.42,"sixtyDayClose":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AARD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524145519","title":"Aardvark Therapeutics Price Target Maintained With a $50.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2524145519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524145519?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:16","pubTimestamp":1743520560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 11:16 ET (15:16 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2524897401","title":"Aardvark Therapeutics FY24 EPS (5.15) Down From ($1.82) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2524897401","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524897401?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:15","pubTimestamp":1743452149,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics FY24 EPS (5.15) Down From ($1.82) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44571255/aardvark-therapeutics-fy24-eps-5-15-down-from-1-82-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2524097441","title":"Press Release: Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2524097441","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524097441?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:10","pubTimestamp":1743451800,"startTime":"0","endTime":"0","summary":"-- Lead candidate ARD-101 demonstrated clinical activity and was generally. well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome ,with meaningful reductions in hyperphagia (up to a 16-point HQ-CT. reduction, with an average reduction of approximately 8 points among. subjects that followed trial protocol) observed during the 28-day dosing. -- DEXA scans analysis from the PWS Phase 2 trial data measuring body. composition indicated a trend toward decreased body fat (approximately. -- Aardvark bolstered its cash runway through the successful completion of. SAN DIEGO, March 31, 2025  -- Aardvark Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today reported financial results for the full year ended December 31, 2024, and provided business highlights.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PWS","AARD","IPO"],"gpt_icon":0},{"id":"2522658517","title":"BUZZ-Ultragenyx Pharma up after JPMorgan PT raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2522658517","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522658517?lang=en_us&edition=fundamental","pubTime":"2025-03-27 23:34","pubTimestamp":1743089680,"startTime":"0","endTime":"0","summary":"BUZZ-Ultragenyx Pharma up after JPMorgan PT raise** Shares of drugmaker Ultragenyx Pharmaceutical RARE.O rise 2% to $38.75** JPMorgan raises RARE's target price to $117 from $104** Believes RARE is uniquely positioned in the long term with a broad and diverse pipeline of orphan disease assets and a highly regarded management team - JPMorgan ** 19 of 20 brokerages rate the stock \"buy\" or higher, one \"hold\"; their median PT is $87, according to data compiled by LSEG** Up to last close, stock had fallen ~10% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL3N3QA1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","BK4139","RARE"],"gpt_icon":0},{"id":"2522379307","title":"Aardvark Therapeutics Is Maintained at Buy by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2522379307","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522379307?lang=en_us&edition=fundamental","pubTime":"2025-03-27 22:25","pubTimestamp":1743085500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2025 10:25 ET (14:25 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2522371118","title":"Aardvark Therapeutics price target raised to $26 from $22 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2522371118","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522371118?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:41","pubTimestamp":1743075663,"startTime":"0","endTime":"0","summary":"BofA analyst Tim Anderson raised the firm’s price target on Aardvark Therapeutics (AARD) to $26 from $22 and keeps a Buy rating on the shares after...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-price-target-raised-to-26-from-22-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-price-target-raised-to-26-from-22-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD"],"gpt_icon":0},{"id":"2518220552","title":"Aardvark Therapeutics Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220552?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:04","pubTimestamp":1741615472,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT13T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0},{"id":"2518274832","title":"BofA Initiates Aardvark Therapeutics at Buy With $22 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274832","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518274832?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:00","pubTimestamp":1741615239,"startTime":"0","endTime":"0","summary":"Price: 10.60, Change: +0.47, Percent Change: +4.64","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD"],"gpt_icon":0},{"id":"2518226504","title":"Aardvark Therapeutics Initiated at Buy by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226504?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:48","pubTimestamp":1741610880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 10, 2025 08:48 ET (12:48 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2518222805","title":"Morgan Stanley Initiates Aardvark Therapeutics at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222805","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518222805?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:05","pubTimestamp":1741608347,"startTime":"0","endTime":"0","summary":"Morgan Stanley Initiates Aardvark Therapeutics at Overweight","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD"],"gpt_icon":0},{"id":"2518284522","title":"Cantor Fitzgerald Initiates Aardvark Therapeutics at Overweight With $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2518284522","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518284522?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:02","pubTimestamp":1741608120,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald Initiates Aardvark Therapeutics at Overweight With $50 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD"],"gpt_icon":0},{"id":"2518496372","title":"RBC Initiates Aardvark Therapeutics at Outperform With $21 Price Target, Speculative Risk Qualifier","url":"https://stock-news.laohu8.com/highlight/detail?id=2518496372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518496372?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:36","pubTimestamp":1741603015,"startTime":"0","endTime":"0","summary":"RBC Initiates Aardvark Therapeutics at Outperform With $21 Price Target, Speculative Risk Qualifier","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD"],"gpt_icon":0},{"id":"2518524573","title":"Aardvark Therapeutics initiated with an Outperform at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2518524573","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518524573?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:10","pubTimestamp":1741601420,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams initiated coverage of Aardvark Therapeutics (AARD) with an Outperform rating and $21 price target Aardvark Thera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-initiated-with-an-outperform-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aardvark-therapeutics-initiated-with-an-outperform-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD"],"gpt_icon":0},{"id":"2514707819","title":"Kenneth Griffin Reports 5.6% Passive Stake in Aardvark Therapeutics as of Feb 14 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2514707819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514707819?lang=en_us&edition=fundamental","pubTime":"2025-02-25 06:58","pubTimestamp":1740437900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF1YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0},{"id":"2511311579","title":"Sector Update: Health Care Stocks Mixed Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2511311579","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511311579?lang=en_us&edition=fundamental","pubTime":"2025-02-14 03:02","pubTimestamp":1739473343,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed Thursday afternoon with the NYSE Health Care Index easing 0.1% and the Health Care Select Sector SPDR Fund  increasing 0.1%.The iShares Biotechnology ETF  rose 0.6%.In sector news, the US Senate confirmed Robert F. Kennedy Jr. as head of the US Department of Health and Human Services.In corporate news, Pliant Therapeutics'  shares surged 25% after the company started assembling an external expert panel to evaluate unblinded data from the phase 2b trial of bexotegrast in people with idiopathic pulmonary fibrosis.GE Healthcare Technologies  shares jumped 9.3% after the company reported higher Q4 adjusted earnings and revenue.Aardvark Therapeutics  shares debuted on Nasdaq with an opening price of $15.18, below the initial public offering price of $16. The stock fell 20% in recent trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","XLV","AARD","GEHC","LU0124676726.USD","BK4585","BK4581","BK4082","IBB","BK4588","PLRX","LU0689626769.HKD"],"gpt_icon":0},{"id":"2511659578","title":"Aardvark Therapeutics Shares Below IPO Price on Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2511659578","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511659578?lang=en_us&edition=fundamental","pubTime":"2025-02-14 01:16","pubTimestamp":1739466984,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics  shares debuted on Nasdaq Thursday with an opening price of $15.18, below the initial public offering price of $16.The shares more recently were changing hands at roughly $14 apiece, further down 13%.The stock debuted on the Nasdaq Global Market under the ticker symbol \"AARD.\"The IPO consists of 5.9 million shares to raise $94.2 million and the company has granted underwriters an option to buy up to an additional 883,200 shares.Price: 13.87, Change: -2.13, Percent Change: -13.31","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD","LU2210150020.SGD","BK4585","IE00BKPKM429.USD","LU2095319765.USD","LU2210149790.SGD","BK4588","BK4112","IE00BGHQF748.EUR","NDAQ","NQmain","IE00B3QW5Z07.USD","IE00B64PRP62.GBP",".IXIC"],"gpt_icon":0},{"id":"2511511755","title":"Aardvark Therapeutics Prices $94.2 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2511511755","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511511755?lang=en_us&edition=fundamental","pubTime":"2025-02-13 17:41","pubTimestamp":1739439711,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics  said late Wednesday it priced an initial public offering of about 5.9 million common shares at $16 each.The company anticipates raising approximately $94.2 million in gross proceeds.The underwriters of the offering, expected to close on Friday, have an option to buy 883,200 more shares.The shares are scheduled to begin trading on the Nasdaq Global Select Market on Thursday under the ticker symbol \"AARD.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AARD"],"gpt_icon":0},{"id":"2511366563","title":"BRIEF-Aardvark Therapeutics Prices IPO Of 5.9 Million Shares At $16.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2511366563","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511366563?lang=en_us&edition=fundamental","pubTime":"2025-02-13 11:41","pubTimestamp":1739418069,"startTime":"0","endTime":"0","summary":"BRIEF-Aardvark Therapeutics Prices IPO Of 5.9 Million Shares At $16.00 Per ShareFeb 12 (Reuters) - Aardvark Therapeutics Inc AARD.O:AARDVARK THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERINGAA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUAJHL5N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2511568727","title":"Aardvark Therapeutics Announces Pricing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2511568727","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511568727?lang=en_us&edition=fundamental","pubTime":"2025-02-13 11:38","pubTimestamp":1739417923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUAJHL5N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0},{"id":"2511456872","title":"Aardvark Therapeutics Inc - Prices IPO of 5,888,000 Shares at $16.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2511456872","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511456872?lang=en_us&edition=fundamental","pubTime":"2025-02-13 11:38","pubTimestamp":1739417923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUAJHL5N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AARD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"AARD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AARD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AARD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AARD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AARD","date":"2025-04-14","current":-7.524231,"percent":0.974359,"low":-51.17654,"twenty":-38.704298,"median":-29.342909,"eighty":-9.574567,"high":-7.397773,"avg":-27.624545,"sd":11.83582,"marketCap":154908868},"quantilePoints":[{"date":"2025-02-21","current":-51.17654,"twenty":-46.993414,"median":-42.216938,"eighty":-39.920668,"marketCap":368880503},{"date":"2025-02-28","current":-39.75453,"twenty":-42.139802,"median":-40.229211,"eighty":-39.232381,"marketCap":286550651},{"date":"2025-03-07","current":-28.243517,"twenty":-40.603022,"median":-39.176012,"eighty":-36.900511,"marketCap":203579269},{"date":"2025-03-14","current":-31.091602,"twenty":-40.336014,"median":-37.766803,"eighty":-30.723725,"marketCap":224108270},{"date":"2025-03-21","current":-27.23482,"twenty":-39.944402,"median":-34.681377,"eighty":-29.198812,"marketCap":196308580},{"date":"2025-03-28","current":-26.404128,"twenty":-39.576524,"median":-30.913597,"eighty":-27.946841,"marketCap":190320955},{"date":"2025-04-04","current":-9.026143,"twenty":-39.119644,"median":-30.068072,"eighty":-27.341623,"marketCap":185830236},{"date":"2025-04-11","current":-7.397773,"twenty":-38.751766,"median":-29.400552,"eighty":-17.252871,"marketCap":152305358},{"date":"2025-04-14","current":-7.524231,"twenty":-38.704298,"median":-29.342909,"eighty":-9.574567,"marketCap":154908868}],"updateTime":1744738215421}}}